Figure 3.
Forest plot of network meta-analysis of noninvasive technique-based outcomes: (A) liver fat content by 1H-MRS and (B) liver fat content by CAP. 1H-MRS, proton magnetic resonance spectroscopy; CAP, controlled attenuation parameter; MD, mean difference; CI, confidence interval; GLP-1RA, glucagon-like peptide-1 receptor agonist; TZD, thiazolidinedione.